Important Notes:

In January 2021, BEBIG Medical GmbH took over the global production and distribution structures of the HDR brachytherapy products of Eckert & Ziegler BEBIG GmbH including Mick Radio-Nuclear Instruments, Inc.

Below news are related to the HDR brachytherapy business and is quoted originally from the website: https://www.ezag.com/home/press/press_releases/detail/?tx_ttnews%5Btt_news%5D=126&cHash=e912301098f361350301ef742822c48c

Original Content:

Eckert & Ziegler Strahlen- und Medizintechnik has won a tender in Bangladesh through its subsidiary Eckert & Ziegler BEBIG to equip Bangladeshi cancer clinics with modern cancer irradiation equipment. The devices from the MultiSource® series worth €3.1 million will provide clinics with a full range of options for efficiently treating gynecological tumors, with a focus on healing cervical cancer, across the whole of East Bengal. Bangladesh has one of the world’s highest mortality rates from this type of malignant tumor. There are still few hospitals where women with cancer can be effectively treated. 
“We are particularly proud of this order,” said Abel Luzuriaga, Member of the Executive Board and responsible for the medical device division at Eckert & Ziegler. “We have provided the first clinics in Bangladesh with equipment several years ago and have now received a subsequent order for deliveries on a large scale. Even if the order volume doesn’t seem all that large at first, the devices will make a significant difference to the lives of tens of thousands of women – and their children. Cervical cancer often occurs at a relatively young age and in many cases affects mothers.” 
The MultiSource® line of cancer irradiation equipment with integrated planning software became the most opted equipment and was chosen on account of its long use of miniaturized cobalt-60 technology, which is unrivaled in the market. They offer a high degree of flexibility and versatility and a cost-effective solution for treating cancer. The devices operate at about a sixth of the cost of conventional systems. 
“We are pleased to see that emerging countries in Asia, Africa and South America are increasingly gaining access to the latest medical infrastructure that has long been available in other parts of the world. Of course, these countries have to think twice before they invest. Our range of MultiSource® devices is exactly what decision-makers are looking for,” Luzuriaga added, “which is clearly the reason they have ordered more.”
In the last few years, Eckert & Ziegler has already equipped more than 250 cancer clinics with these systems, and even nationwide in some countries. The equipment is scheduled for delivery to Bangladesh Government radiation clinics between December 2013 and March 2014.
The order is being funded by a consortium that includes the World Bank, the World Health Organization, the EU and the KfW Development Bank as part of the Health, Population & Nutrition Sector Development Program. The goal of the five-year program is to guarantee basic health care for the treatment of new cancer cases, which are on the rise in Bangladesh.

About BEBIG Medical GmbH:

BEBIG Medical GmbH (“BEBIG Medical”) is a global provider of high quality radiation therapy products for cancer treatment headquartered in Berlin, Germany. Preceded by the high dose brachytherapy business unit of Eckert & Ziegler AG, BEBIG Medical has a heritage of more than 40 years’ experience in brachytherapy field and continues to provide affordable healthcare with proven clinical outcomes via strong and viable technology.BEBIG Medical’s US subsidiary, Mick Radio-Nuclear Instruments, Inc., is also known internationally for its manufacturing expertise in the field of applicators and accessories to advance brachytherapy. With a team of professionals and offices in Europe, United States and Asia, the company is empowered to serve customers in more than 65 countries and regions together with a worldwide distribution network.

Contact:

Crystal Chen, Chief Commercial Officer: crystal.chen@bebigmedical.com